Table 2 Assay test results of artemether–lumefantrine samples (N = 74) collected from low and high malaria transmission settings in Uganda, June-December 2021
From: Pharmacopeial quality of artemether–lumefantrine anti-malarial agents in Uganda
Brand name | Artemether label claim (mg) | Number of samples tested n (%) | Number of samples with artemether content outside pharmacopeiala range (90–110%) n (%) | Number of samples with lumefantrine content outside pharmacopeiala range (90–110%) n (%) |
|---|---|---|---|---|
LONART | 20/120 | 20 (27%) | 4 (5.4%) | 2 (2.7%) |
40/240 | 1 (1.4%) | 0 | 0 | |
80/480 | 3 (4.1%) | 0 | 0 | |
LONART-DS | 80/480 | 1 (1.4%) | 0 | 0 |
ARTEFAN | 20/120 | 12 (16.2%) | 0 | 0 |
40/240 | 1 (1.4%) | 0 | 0 | |
60/360 | 1(1.4%) | 0 | 0 | |
80/480c | 1(1.4%) | 1(1.4%) | 1 (1.4%) | |
LUMARTEM | 20/120 | 2 (2.7%) | 0 | 0 |
80/480 | 1 (1.4%) | 0 | 0 | |
CO-METHER | 20/120 | 5 (6.8%) | 1 (1.4%) | 0 |
KOMEFAN-140 | 20/120 | 1 (1.4%) | 1(1.4%) | 0 |
COMBIART | 20/120 | 5 (6.8%) | 0 | 0 |
LUMERAX | 20/120 | 1 (1.4%) | 1 (1.4%) | 0 |
LARIACT | 20/120 | 3 (4.1%) | 0 | 1 (1.4%) |
Cach-ARTb | 20/120 | 2 (2.7%) | 2 (2.7%) | 1 (1.4%) |
LUMAREN | 20/120 | 2 (2.7%) | 0 | 0 |
COARTEM | 20/120 | 1 (1.4%) | 0 | 0 |
KOMEFAN | 20/120 | 1 (1.4%) | 0 | 0 |
LUMITER | 20/120 | 6 (8.1%) | 1 (1.4%) | 0 |
Not Indicated | 20/120 | 4 (5.4%) | 0 | 0 |
Total number | 74 (100%) | 11 (14.9%) | 5(6.8%) | |